Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Eisai: current focus and pipelines – interview with Gary Hen...

pharmaphorum interviews Gary Hendler of Eisai to hear of Eisai’s current pipeline and what disease areas it will be focussing on. Eisai recently announced that it would be transferring the global solid dose manufacturing of its new...

Articles

Media perspectives: Ron Leuty

We speak with San Francisco Business Times’ biotech reporter, Ron Leuty, on some of the most interesting biotech stories in the past few years and his views on the rise of personalised medicine. It’s been a whole month since our last media perspectives interview – this year sure is going fast! The aim of this...

Articles

Pharma gets social: diffusion of pharma social media innovat...

Daniel Ghinn’s latest piece takes a look at Diffusion of Innovators model and how this has influenced social media within pharma. When I founded Creation Healthcare back in 1998, in the same year that doctors.net.uk launched as an email service...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.